Senior Director, Drug Development Services – Cardiometabolic
Posted 2hrs ago
Employment Information
Report this job
Job expired or something wrong with this job?
Job Description
Senior Director guiding ICON’s Cardiometabolic drug development and consulting services. Advising pharmaceutical leaders and designing liver disease trials across Phases I–IV.
Responsibilities:
- Lead strategic Cardiometabolic drug development design and deliver tailored, asset-focused solutions across liver diseases
- Own end-to-end protocol development, including design, scientific review, and evaluation for Phase I–IV clinical trials
- Advise senior client stakeholders on Cardiometabolic development strategy and data interpretation
- Lead proposal development, study strategy, and bid defense activities
- Build and maintain relationships with Cardiometabolic KOLs, advisory boards, and regulatory authorities
- Develop Cardiometabolic-focused service offerings and support innovation and growth in liver disease drug development
- Provide training, mentorship, and thought leadership to internal teams and external partners
- Participate in portfolio reviews, governance discussions, and scientific oversight
- Support operational teams with high-level scientific input, investigator meetings, and study discussions
- Represent ICON at Cardiometabolic congresses and scientific forums
Requirements:
- Deep, recognized expertise in Cardiometabolic and liver disease drug development
- Strong understanding of Cardiometabolic clinical trial design, biomarkers, endpoints, fibrosis staging, histologic and non-invasive markers, and evolving therapeutic landscapes
- Proven ability to operate in a strategic, client-facing, consultative environment within pharmaceutical or clinical research settings
- Experience engaging and influencing senior scientific and clinical stakeholders across industry and academia
- Excellent communication and presentation skills, with ability to translate complex Cardiometabolic data into actionable development insights
- Collaborative, global mindset with strong cross-functional leadership capability
- MD required, ideally with specialization or substantial clinical/research experience in Cardiometabolic diseases
- Legal right to work in the country where the role is based
Benefits:
- Competitive base salary and performance related incentives
- Medical, dental, and vision coverage where applicable
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes and wellbeing resources
- Learning and development opportunities through structured training and career pathways
- 20–40% domestic and international travel opportunity
- Highly visible, impact-driven role shaping the future of Cardiometabolic drug development
















